Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 11, 2008
Influence of extended-spectrum beta-lactams on gram-negative bacterial resistanceJoseph A Paladino, Jenna L Sunderlin, Mendel E Singer, et al.
American Journal of Surgery|May 31, 1988
Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moietyJ J Schentag, L S Welage, J S Williams, et al.
International Journal of Antimicrobial Agents|June 26, 2007
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled studyJerome J Schentag, Keith P Klugman, Victor L Yu, et al.
Journal of Pediatric Surgery|June 8, 1999
Prenatal diagnosis of congenital cystic adenomatoid malformation and its postnatal presentation, surgical indications, and natural historyK van Leeuwen, D H Teitelbaum, R B Hirschl, et al.
International Journal of Antimicrobial Agents|October 6, 2014
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrationsJoseph A Paladino, David M Jacobs, Ryan K Shields, et al.
ATS Scholar|May 25, 2026
Virtual Reality Simulation for Tracheostomy Emergencies: A Randomized Educational InterventionJordan W Talan, Mark H Adelman, Molly Forster, et al.
Infection Control and Hospital Epidemiology|April 1, 1997
Changing the infection control paradigm from off-line to real time: the experience at Millard Fillmore Health SystemJ R Carr, P Fitzpatrick, J L Izzo, et al.
Seminars in Respiratory Infections|January 22, 1998
In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistanceJ J Schentag, M C Birmingham, J A Paladino, et al.
International Journal of Antimicrobial Agents|October 7, 2008
A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibioticThomas M File, Scott V Monte, Jerome J Schentag, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratoryJ J Schentag, C H Ballow, A L Fritz, et al.
Pageof 4